Global Mycology Immunoassays Testing Market Growth (Status and Outlook) 2023-2029

Global Mycology Immunoassays Testing Market Growth (Status and Outlook) 2023-2029

The frequency of invasive fungal infections has dramatically increased in the recent years and has high mortality and morbidity. Accurate and early diagnosis is very important for the appropriate antifungal therapy. Conventional techniques like microbiology, radiological and histological remain the basis of diagnosis but have limited impact on clinical decision making. There is always a need to characterize fungi accurately and quickly, which can be done by mycology immunoassays test. The fungi are parasitic and saprophytic eukaryotic organisms. The diagnostic methods for fungal infections are direct examination, radiology, and fungal culture and non-culture methods.

LPI (LP Information)' newest research report, the “Mycology Immunoassays Testing Industry Forecast” looks at past sales and reviews total world Mycology Immunoassays Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Mycology Immunoassays Testing sales for 2023 through 2029. With Mycology Immunoassays Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mycology Immunoassays Testing industry.

This Insight Report provides a comprehensive analysis of the global Mycology Immunoassays Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mycology Immunoassays Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mycology Immunoassays Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mycology Immunoassays Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mycology Immunoassays Testing.

The global Mycology Immunoassays Testing market size is projected to grow from US$ 1756.6 million in 2022 to US$ 2572.7 million in 2029; it is expected to grow at a CAGR of 5.6% from 2023 to 2029.

United States market for Mycology Immunoassays Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Mycology Immunoassays Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Mycology Immunoassays Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Mycology Immunoassays Testing players cover Roche, Abbott, Siemens, Beckman Coulter, Ortho-Clinical Diagnostics, bioMérieux, ELITechGroup, MiraVista Diagnostics and Autobio Diagnostics CO.,Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Mycology Immunoassays Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
ELISA
Rapid Tests
ELISPOT
Polymerase Chain Reaction (PCR)

Segmentation by application
Hospitals
Blood Banks
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Abbott
Siemens
Beckman Coulter
Ortho-Clinical Diagnostics
bioMérieux
ELITechGroup
MiraVista Diagnostics
Autobio Diagnostics CO.,Ltd.
CapitalBio Corporation

Please note: The report will take approximately 2 business days to prepare and deliver.